Ticagrelor and Lenalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ticagrelor (ticagrelor) and Lenalidomide (lenalidomide). Common drug interactions include cytokine release syndrome among females and acute myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Ticagrelor and Lenalidomide. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Ticagrelor?

Ticagrelor has active ingredients of ticagrelor. eHealthMe is studying from 8,499 Ticagrelor users. Check the latest studies of Ticagrelor.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

On Aug, 07, 2026

12 people who take Ticagrelor and Lenalidomide together, and have interactions are studied.

Ticagrelor and Lenalidomide drug interactions.

What are the common drug interactions of Ticagrelor and Lenalidomide, by gender? *:

female:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Pneumonia

male:

Acute myocardial infarction (acute heart attack)
Purpura (purplish discoloration of the skin)
Cardiac failure
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Ticagrelor and Lenalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Acute myocardial infarction (acute heart attack)
Purpura (purplish discoloration of the skin)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pneumonia

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 41.67%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 33.33%
Seasonal Affective Disorder (a type of depression that occurs at a certain time of the year, usually in the winter): 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 3 people, 25.00%
Chest Pain: 3 people, 25.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 8.33%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 1 person, 8.33%
Hypokalemia (low potassium): 1 person, 8.33%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ticagrelor and Lenalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously